Kroeger Christopher A. has filed 7 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 23145 shares of MapLight Therapeutics, Inc. ($MPLT) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 23145 | $0.00 | 1,750,941.0000 | 45,373,033 | 1.34% | 0.05% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 93955 | $0.00 | 93,955.0000 | 45,373,033 | 9999.99% | 0.21% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | F | Voting Common Stock | 204146 | $17.98 | 1,727,796.0000 | 45,373,033 | 10.57% | 0.45% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 225693 | $0.00 | 326,883.0000 | 0 | 223.04% | 0.00% |
| Oct. 28, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | C | Series C Preferred Stock | 65477 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | C | Voting Common Stock | 3895 | $0.00 | 330,778.0000 | 0 | 1.19% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 916164 | $0.00 | 916,164.0000 | 0 | 9999.99% | 0.00% |